Tango Therapeutics: Third Rock Ventures IV Sells 302,194 Shares at $7/Share

Tango Therapeutics, Inc. (TNGX) has announced that 10% Owner Third Rock Ventures IV, L.P. has disposed of 302,194 shares at a price of $7 per share on August 22, 2025.

Tango Therapeutics, Inc. (TNGX), a clinical-stage biotechnology company, has reported that its 10% owner, Third Rock Ventures IV, L.P., has disposed of 302,194 shares of the company's common stock. The transaction occurred on August 22, 2025, at an average price of $7 per share [1].

The disposal of these shares was reported in a recent SEC Form 4 filing submitted by Third Rock Ventures IV, L.P. The filing details the transaction and provides information about the beneficial ownership of the shares. According to the filing, the shares were sold in multiple transactions at prices ranging from $7.00 to $7.05, inclusive [1].

Third Rock Ventures IV, L.P. is a venture capital firm that has invested in various biotechnology and pharmaceutical companies. The firm's investment in Tango Therapeutics, Inc. is significant, with the firm holding a 10% stake in the company. The disposal of shares by the firm is likely a strategic move to manage its investment portfolio and liquidate some of its holdings.

The disposal of these shares by Third Rock Ventures IV, L.P. may have implications for the stock price of Tango Therapeutics, Inc. (TNGX). The market may react to the news of the share disposal, especially if it is seen as a sign of the firm's confidence in the company's future prospects. However, it is important to note that the disposal of shares by a single investor, even one as significant as Third Rock Ventures IV, L.P., may not have a substantial impact on the overall market sentiment towards the company.

Investors and financial professionals should closely monitor the news and market reactions to the share disposal by Third Rock Ventures IV, L.P. to assess its potential impact on Tango Therapeutics, Inc. (TNGX) and the broader biotechnology sector.

References:
[1] https://www.stocktitan.net/sec-filings/TNGX/form-4-tango-therapeutics-inc-insider-trading-activity-b301b42a2a30.html